Invokana now indicated to reduce the risk of major cardiovascular events Health Canada approves new tests for diagnosing heart attacks fasterTwo innovative assays that can shorten the time required to diagnose life-threatening heart attacks have been licensed for sale by Health Canada. Bariatric surgery may reduce risk of macrovascular events in severely obese type 2 diabetes patients Insurance coverage for weight loss surgeries should be expanded for appropriate patients 2018 Consolidated Canadian guideline for preventing and managing cardiovascular disease in primary care C-CHANGE guideline combines recommendations from nine Canadian cardiovascular-related guidelines to meet primary care needs Nearly 10% of high-risk older patients are prescribed NSAIDs for musculoskeletal pain But short-term use is not associated with an increased risk of cardiovascular or renal complications New C-CHANGE guideline provides comprehensive recommendations to manage heart disease Taking a daily 'baby' Aspirin can be risky for healthy seniors: study For healthy seniors who have no need to take aspirin, there is no benefit. However, it is still appears to be useful for people who already have stroke or heart disease. Aspirin disappoints for avoiding first heart attack, stroke, research finds Although it’s been used for more than a century, aspirin’s value in many situations is still unclear New Interim Order will permit import of alternate epinephrine autoinjector during EpiPen shortage Auvi-Q 0.3 mg autoinjector expected to be available in pharmacies by September 7th US Food and Drug Administration approves first generic EpiPen, extends EpiPen shelf life Canadian company seeks to market EpiPen alternative, while Food Allergy Canada provides advice concerning EpiPen shortage First Previous 28 29 30 31 32 Next Last